Showing 43 Result(s)

Neuralink’s First Human Trial Patient

In the annals of scientific history, Noland Arbaugh’s name will forever be etched as the first-ever human trial patient—a trailblazer who dared to defy the limits of possibility and embrace the unknown. As Neuralink continues to push the boundaries of what is achievable, Arbaugh’s story will serve as a reminder of the boundless potential that lies within the human spirit.

Dyslexia & AI

Dyslexia is a neurological disorder that affects a person’s ability to read, write, spell, and sometimes even speak. It is a common learning disability that affects approximately 1 in 10 people worldwide. Dyslexia can vary in severity, with some people experiencing mild difficulties, while others struggle with severe challenges.